Portolan Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Portolan Capital Management, LLC holds 4 biotech & pharma companies tracked by BioSniper, totaling $36.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
4
Total value held
$36.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Pulse Biosciences Inc Common Stock (DE) (PLSE)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PLSEPulse Biosciences Inc Common Stock (DE) | 733,372 | $15.8M |
| CADLCandel Therapeutics, Inc. | 2,894,325 | $14.2M |
| TLXTelix Pharmaceuticals Limited | 541,267 | $5.2M |
| FLGTFulgent Genetics Inc. | 106,642 | $1.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.